Cytofluorographic and molecular identification of a CD8-positive, TCR-α/β-negative intraocular T cell lymphoma: a case report and review of the literature by Alvaro D Saenz et al.
BioMed CentralJournal of Medical Case Reports
ssOpen AcceCase report
Cytofluorographic and molecular identification of a CD8-positive, 
TCR-α/β-negative intraocular T cell lymphoma: a case report and 
review of the literature
Alvaro D Saenz1, Alexandra Amador1, Brianna M Ruiz1, Janet Davis2 and 
Phillip Ruiz*1,3
Address: 1Department of Pathology, University of Miami, Miami, Florida, USA, 2Department of Ophthalmology, University of Miami, Miami, 
Florida, USA and 3Department of Surgery, University of Miami, Miami, Florida, USA
Email: Alvaro D Saenz - dsaenz@jmh.org; Alexandra Amador - aamador@med.miami.edu; Brianna M Ruiz - bruiz@miami.edu; 
Janet Davis - jdavi@med.miami.edu; Phillip Ruiz* - pruiz@med.miami.edu
* Corresponding author    
Abstract
Introduction: Cytofluorographic and molecular techniques are effective adjuncts in diagnosing
intraocular lymphoma. Primary intraocular lymphoma is an uncommon entity predominantly of B
cell origin and rarely with a T cell phenotype. The aim of the present paper is to report a case of
a CD8-positive, TCR-α/β-negative intraocular T cell lymphoma and review the literature.
Case presentation: T cell neoplasia was detected based on flow cytometric demonstration of an
abnormal T cell population and polymerase chain reactions for immunoglobulin and T-cell receptor
rearrangements demonstrating evidence of monoclonality. Flow cytometry revealed a T cell
population aberrantly expressing T-cell lineage markers. This T cell population expressed CD2,
bright CD3, CD8, bright CD7, CD38, CD69, and variable CD25. T-cell receptor γ gene
rearrangement studies demonstrated evidence of T-cell gene rearrangement confirming that the T
cells were monoclonal.
Conclusion: We herein report the rare case of a TCR α/β-negative CD8+ intraocular T-cell
lymphoma suggestive of gamma/delta origin diagnosed by flow cytometry and polymerase chain
reaction.
Introduction
The occurrence of intraocular lymphoma can be divided
into metastatic lymphoma to the eye usually presenting as
uveal small cell non Hodgkin lymphoma, or primary
intraocular lymphomas (PIOL) that characteristically are
vitreoretinal large B cell variety [1]. The majority of
PIOL's, a subset of primary central nervous system lym-
phoma (PCNL), develop central nervous system involve-
ment whereas only a minority of PCNL's have intraocular
disease [2,3]. PIOL has a broad age range, is more frequent
in women, typically is bilateral, and has a propensity to
mimic benign inflammatory diseases. Immunodeficiency
and immune dysregulation are predisposing risk factors
[1,3]. We have previously shown that the cytomorpho-
logic diagnosis of PIOL can be markedly enhanced by
flow cytometric analysis of cell populations in vitreous
fluid [4].
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posed of B cells with T cell lymphomas being particularly
rare. Patients with the latter disease sometimes have a his-
tory of mycosis fungoides, systemic T cell lymphoma/
leukemia, acquired immunodeficiency syndrome, or
infection with human T cell lymphotropic virus type I [1].
In a series study by Coupland SE et al, some T cell lym-
phomas in the periorbital or orbital region were CD8+
[5]. In general, most systemic T cell lymphomas express
the α/β T cell receptor (TCR) whereas a minority has the
γ/δ TCR [6]. However TCR rearrangement in ocular T cell
lymphomas has not been well studied or described.
Herein, we report a case of an intraocular CD8+, TCR-α/β-
negative T-cell lymphoma without apparent systemic,
cutaneous, or central nervous system involvement, diag-
nosed by flow cytometry and molecular assessment of
antigen receptor rearrangement.
Case presentation
An 83-year old Hispanic woman presented to Bascom
Palmer Eye Institute with loss of vision in the left eye,
floaters and flashing lights for one to three months. Her
past medical history was significant for hypertension, car-
diomyopathy, chronic bronchitis, and dementia with psy-
chosis controlled with haloperidol and evaluated with an
MRI examination of the brain one month previously that
had revealed no mass lesions. A scaly rash had been
present on the left side of the face, arm, and leg for over 1
year for which she had consulted three dermatologists
without a definite diagnosis; it had cleared substantially
when she took an antibiotic for a gastrointestinal infec-
tion, but was still present. The lesion was not biopsied.
Ocular examination revealed 20/30 vision in the right eye
and 20/400 in the left eye. The vitreous fluid in the left eye
contained cells and there was consideration of an old,
decolorized vitreous hemorrhage or an inflammatory
reaction. There was no anterior segment inflammation. A
small white fibrotic macular lesion was barely visible.
Vision improved to 20/80, but the vitreous cells increased
in the periphery these findings suggested the presence of a
lymphoproliferative disorder and the diagnosis of intraoc-
ular lymphoma was considered 5 months after the initial
examination. Pars plana vitrectomy was performed and
the vitreous was sent for flow cytometry and cytology
studies. The macular lesion was unchanged; there were no
other retinal lesions. Vision improved slightly to 20/70
two weeks after surgery.
Evaluation with her primary care physician revealed a
white blood cell count of 4.8 × 100 cells/mm^3, absolute
lymphocyte count 400 cells/mm^3, hemoglobin 12.0
gm/dl, hematocrit 35.7%, and platelets 127,000/mm^3.
The patient refused additional evaluation and was alive 7
months after the surgery.
Materials and methods
Vitreous humor was collected using a pars plana vitrec-
tomy methodology with cutting and aspiration into a
syringe. The specimens were immediately submitted to
the pathology department for processing. Specimens were
placed in Roswell Park Memorial Institute Media (RPMI,
Mediatech, Herendon, VA) for flow cytometry and 95%
ethanol for cytologic analysis.
0.5 cc of the cytology specimen of undiluted vitreous was
pipetted into a cytospin chamber and spun at 1000 rpm
for five minutes with the concentrated cells then fixed
onto a glass slide. The specimen was subsequently stained
with a Papanicolau procedure [7].
The diluted flow cytometry specimen was subjected to red
cell lysis with ammonium chloride. Cell counts were
obtained with a hemocytometer, and cell viability was
assessed using propidium iodide methodology. A limited
number of cells were available (1.5 × 105) and aliquots
were stained using a four color technique that utilizes
monoclonal antibodies directly conjugated to either fluo-
rescein, phycoerythrin, peridinin chlorophyll protein, or
allophycocyanin. The scope of hematopoietic antigens
examined for leukemia-lymphoma analysis in various
four color combinations included CD45, TCR α/β, CD2,
CD3, CD4, CD5, CD7, CD8, CD56 CD19, CD20, CD22,
CD23, CD79a, kappa, lambda, CD11c, CD13, CD14,
CD64, TdT (Supertechs, Inc, Bethesda, Md), CD10, CD38,
CD25, CD69, HLADR, and CD138. Unless specified, all
antibodies were purchased from Becton Dickinson (San
Jose, CA). The cells were analyzed using a Becton-Dickin-
son FACSCalibur™ flow cytometer (Becton Dickinson,
San Jose, CA).
Multiplex PCR reactions for Antigen Receptor (Immu-
noglobulin and T-cell receptor) rearrangements were per-
formed as previously described [8]. Reagents from
Invivoscribe Technologies, Inc. were used as per manufac-
turer's directions. DNA was purified from the CSF using
Qiamp spin columns (Qiagen, Inc. Valencia, CA), quanti-
tated and amplified using a ABI Geneamp 9700 thermal
cycler (Applied Biosystems, Foster City, CA), following
the thermal cycler profile unique to each assay. Detection
was performed using an ABI 3100-Avant Genetic Ana-
lyzer. Fragment analysis using GeneMapper v 3.7 software
was used to detect the fluorescently labeled amplified
products. DNA from normal polyclonal populations gave
a unique Gaussian distribution of amplified products in
the expected size range for the primers used. Monoclonal
populations gave unique, single sized peaks, with or with-
out a significant polyclonal background.Page 2 of 6
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Cytologic examination demonstrated few unremarkable
mononuclear cells that varied in size (small, midsized)
(Figure 1) and which mostly represented unremarkable
lymphocytes. Forward and side scatter analysis revealed
two distinctly sized agranular cell populations, each
which was independently gated and analyzed. Flow
cytometry multiparameter analysis of the gated cell popu-
lations revealed a distinct prominent T cell population
that aberrantly expressed T-cell lineage markers. The larger
sized cell population predominantly showed a T cell phe-
notype and expressed CD2, bright CD3, CD8, bright CD7,
CD38, CD69, and variable CD25 (Figure 2). These cells
failed to express CD4, CD5, or TCR-α/β. Normal T cells
within the smaller sized cell gate expressed normal T cell
lineage markers at typical intensities; B cells, and myelo-
monocytic cells were also identified. Overall, this pheno-
type was interpreted as an atypical T cell population
suggestive of a T cell lymphoproliferative process.
The immunoglobulin κ light-chain and heavy chain did
not show any B cell monoclonality. T-cell receptor γ gene
rearrangement studies demonstrated evidence of T-cell
gene rearrangement (Figure 3) compatible with the T cells
being monoclonal.
Discussion
Intraocular T cell neoplasms are relatively uncommon
and account for less than 1% of intraocular lymphomas.
Patients typically have a history of either mycosis fun-
goides, systemic T cell lymphoma/leukemia, acquired
immunodeficiency syndrome, or infection with human T
cell lymphotropic virus type I [1]. In one study of 7 cases
of orbital and periorbital T cell lymphoproliferative proc-
esses [5], 3 cases were CD8+, however, two of these cases
were systemic tumors involving the eye and the remaining
case was a polyclonal intraocular T cell population with a
different phenotype than the one we have presented. In
general, most systemic T cell lymphomas display surface
α/β T cell receptor (TCR) whereas a minority express the
γ/δ TCR [10]. However TCR rearrangement molecular
analysis in ocular T cell lymphomas has not been well
studied.
In the present case, vitreous fluid cytology, a traditional
study for the diagnosis of intraocular lymphoma, did not
reveal markedly atypical cells. However, multiparameter
flow cytometry analysis demonstrated a distinct promi-
nent T-cell population aberrantly expressing T-cell lineage
markers. This T-cell population expressed CD2, bright
CD3, CD8, CD7, bright CD38, CD69, and variable CD25.
This T-cell population was negative for CD4, CD5, CD56,
and TCR-α/β. PCR analysis of the flow cytometry cell mix-
ture, by showing T-gamma gene rearrangement demon-
strated the monoclonal nature of the T cells. By
comparison, the admixed B cells did not show light chain
gene rearrangement.
Although surface expression of TCR-γ/δ could not be con-
firmed directly because of insufficient specimen, its pres-
ence was strongly inferred from the lack of TCR-α/β
expression. The patient lacked risk factors for systemic T
cell neoplasia including ethnicity, geographical habitat, or
immunodeficiency (e.g., HIV and HTLV). A brain MRI
excluded a primary central nervous system primary, the
peripheral blood cell count and smear did not reveal any
atypical cells, and clinical examination did not reveal any
skin lesions suspicious for mycosis fungoides, lymphade-
nopathy, or organomegaly. The scaly skin lesion
improved with antibiotics. Thus, at this level there was no
evidence of systemic disease. The patient was made aware
of the findings but refused further work up and a bone
marrow biopsy was not performed. Accordingly, we can
only speculate on the primary or metastatic nature of the
disease but the clinical and laboratory findings were indic-
ative of a primary T-cell lymphoma suggestive of gamma/
delta origin.
Gamma delta T cells display a restricted distribution
mainly present in the spleen and certain epithelial sites.
They are not MHC restricted, can secrete a variety of
cytokines and can possess cytotoxic activity. They are
essential in immunity against certain organisms and can
be involved in autoimmune disorders, diabetes, asthma,
and malignancy. Prototypical gamma/delta T-cell neo-
plasms include hepatosplenic gamma/delta T-cell lym-
phoma, mucocutaneous gamma/delta T cell lymphoma,
Papanicolaou stain, 600×Figure 1
Papanicolaou stain, 600×. The corresponding flow cytometry 
cytospin has low cellularity and consists of small medium 
sized non-atypical mononuclear cells with minimal cytoplasm 
and a bland round nucleus consistent with lymphocytes.Page 3 of 6
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Flow cytometry histograms showing gating of small (red) and larger (green) cell populationsigure 2
Flow cytometry histograms showing gating of small (red) and larger (green) cell populations. The larger cell population is pri-
marily composed of atypical T cells.
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Multiplex molecular analysis of antigen receptors for B cell (A) and T cell (B) showing monoclonal spikes with the T cell prim-ers (se  arr ws)Figure 3
Multiplex molecular analysis of antigen receptors for B cell (A) and T cell (B) showing monoclonal spikes with the T cell prim-
ers (see arrows).
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and gamma/delta T-cell large granular lymphocyte (LGL)
leukemia. Hepatosplenic gamma/delta T-cell lymphoma
occurs in young males and has a dismal prognosis. It
presents with hepatosplenomegaly, cytopenias, bone
marrow and peripheral blood involvement, and no lym-
phadenopathy. The malignant cells demonstrate sinusoi-
dal infiltration of the spleen, liver, and bone marrow.
Their immunophenotype is usually CD2+, CD3+, CD4-,
CD5-, CD7+, CD8 variable, CD16+, and CD56+ [6,8-10].
Mucocutaneous gamma/delta T cell lymphoma distinctly
presents with skin or mucosal lesions without splenic or
hepatic involvement and variable peripheral blood infil-
tration. Survival is worse than their TCR-α/β mucocutane-
ous counterparts and varies from aggressive to an indolent
course. The typical immunophenotype is similar to
gamma/delta hepatosplenic lymphoma with CD3+, CD7-
, and variable NK related antigen expression [5,10].
Gamma/delta large granular lymphocyte (LGL) leukemia
is usually an indolent disease presenting with clonal
peripheral blood gamma/delta T cell lymphocytosis, neu-
tropenia, recurrent bacterial infection, and bone marrow
involvement. The malignant cells are usually CD2+,
CD3+, and CD4-. Expression of CD8 and, CD5 are more
frequent than in the other gamma/delta T cell lympho-
mas. This disease has a much better prognosis than the
other two gamma/delta tumors [6,9].
Conclusion
As previously mentioned, we have indirect evidence that
the present case was in fact a true, somewhat indolent
gamma/delta T-cell neoplasm, with no clinical evidence
supporting systemic disease. The phenotype of the tumor
would not be completely compatible with the less aggres-
sive gamma/delta LGL lymphomas since the cells lacked
CD5 expression nor was there neutropenia or recurrent
bacterial infections. The patient's neoplasm was CD7+
and no malignant skin lesions were identified thus the
probability of it representing a metastatic cutaneous
gamma/delta T-cell lymphoma is unlikely. The patient's
tumor immunophenotype is similar to hepatosplenic
gamma/delta T-cell lymphoma, although it was negative
for CD56 which is usually present in these neoplasms;
moreover, the patient does not fit the profile of a young ill
male with organomegaly. Taken together, our evidence
supports this could represent a true primary intraocular
gamma/delta CD8+ T-cell lymphoma although exact
gamma/delta tumor categorization is not feasible.
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